Pfizer Limited · NSE: PFIZER · BSE: 500680

Pfizer

Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 28 Jul 2026.

Q1 FY27 · Standalone

Revenue
653.17₹ Cr
+8.3% vs year ago
Net profit
204.47₹ Cr
+6.6% vs year ago
EPS, basic
44.69₹
+6.6% vs year ago
Net margin
31.3%
−0.5 pts vs year ago
Revenue₹ crore · standalone · last 12 quarters
Q2 FY24: ₹575.21 CrQ3 FY24: ₹539.97 CrQ4 FY24: ₹546.63 CrQ1 FY25: ₹562.86 CrQ2 FY25: ₹588.59 CrQ3 FY25: ₹537.99 CrQ4 FY25: ₹591.91 CrQ1 FY26: ₹603.05 CrQ2 FY26: ₹642.34 CrQ3 FY26: ₹645.03 CrQ4 FY26: ₹629.23 CrQ1 FY27: ₹653.17 CrQ3 ’24Q1 ’25Q3 ’25Q1 ’26Q3 ’26Q1 ’27
Net profit₹ crore · standalone · last 12 quarters
Q2 FY24: ₹148.96 CrQ3 FY24: ₹129.98 CrQ4 FY24: ₹178.86 CrQ1 FY25: ₹150.71 CrQ2 FY25: ₹158.35 CrQ3 FY25: ₹127.60 CrQ4 FY25: ₹330.94 CrQ1 FY26: ₹191.75 CrQ2 FY26: ₹189.02 CrQ3 FY26: ₹141.84 CrQ4 FY26: ₹199.82 CrQ1 FY27: ₹204.47 CrQ3 ’24Q1 ’25Q3 ’25Q1 ’26Q3 ’26Q1 ’27

Quarter by quarter

Standalone · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 2026653.17+8.3%204.47+6.6%44.6928 Jul 2026
Q4 FY26Jan–Mar 2026629.23+6.3%199.82−39.6%43.6812 May 2026
Q3 FY26Oct–Dec 2025645.03+19.9%141.84+11.2%31.0109 Feb 2026
Q2 FY26Jul–Sep 2025642.34+9.1%189.02+19.4%41.3226 Nov 2025
Q1 FY26Apr–Jun 2025603.05+7.1%191.75+27.2%41.9113 Aug 2025
Q4 FY25Jan–Mar 2025591.91+8.3%330.94+85.0%72.3410 Jun 2025
Q3 FY25Oct–Dec 2024537.99−0.4%127.60−1.8%27.8931 Jan 2025
Q2 FY25Jul–Sep 2024588.59+2.3%158.35+6.3%34.6128 Oct 2024
Q1 FY25Apr–Jun 2024562.86+5.9%150.71+61.1%32.9430 Jul 2024
Q4 FY24Jan–Mar 2024546.63−4.5%178.86+38.0%22.3318 May 2024
Q3 FY24Oct–Dec 2023539.97−13.2%129.98−13.7%27.1210 Feb 2024
Q2 FY24Jul–Sep 2023575.21−9.8%148.96−52.1%32.5630 Oct 2023
Q1 FY24Apr–Jun 2023531.36−10.4%93.53+187.3%20.4411 Aug 2023
Q4 FY23Jan–Mar 2023572.64+4.2%129.65+3.1%28.3416 May 2023
Q3 FY23Oct–Dec 2022621.75−8.0%150.66+4.7%32.9309 Feb 2023
Q2 FY23Jul–Sep 2022637.47+0.2%311.07+117.6%67.9911 Nov 2022
Q1 FY23Apr–Jun 2022592.90−20.9%32.55−83.7%7.1108 Aug 2022
Q4 FY22Jan–Mar 2022549.66+2.8%125.79+25.1%27.5021 May 2022
Q3 FY22Oct–Dec 2021675.90+13.9%143.91+1.9%31.4603 Feb 2022
Q2 FY22Jul–Sep 2021636.26+6.9%142.95+8.8%31.2503 Nov 2021
Q1 FY22Apr–Jun 2021749.17+45.5%199.91+60.6%43.6928 Jul 2021
Q4 FY21Jan–Mar 2021534.76+6.5%100.55−2.4%21.9826 May 2021
Q3 FY21Oct–Dec 2020593.49+10.3%141.24+1.6%30.8705 Feb 2021
Q2 FY21Jul–Sep 2020595.41+5.0%131.37−14.8%28.7102 Nov 2020
Q1 FY21Apr–Jun 2020514.89−5.4%124.45+10.3%27.2027 Jul 2020
Q4 FY20Jan–Mar 2020502.01−6.3%103.01−5.9%22.5215 Jun 2020
Q3 FY20Oct–Dec 2019538.18+4.7%139.06+5.4%30.4014 Feb 2020
Q2 FY20Jul–Sep 2019567.06+9.1%154.25+61.0%33.7226 Oct 2019
Q1 FY20Apr–Jun 2019544.40+6.3%112.81+22.8%24.6609 Aug 2019
Q4 FY19Jan–Mar 2019535.66—109.47—23.9328 May 2019
Q3 FY19Oct–Dec 2018513.79—131.94—28.8425 Jan 2019
Q2 FY19Jul–Sep 2018519.74—95.80—20.9414 Nov 2018
Q1 FY19Apr–Jun 2018512.31—91.84—20.0702 Aug 2018

33 filings on record for this company.